The Patent Finder

Bolder Biotechnology, Inc.

Also on record
Records under this name other than the patents Bolder Biotechnology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Back to Bolder Biotechnology, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,229,683Hematopoietic Growth Factor Proteins and Analogs Thereof and Angiotensin Converting Enzyme Inhibitors for Treatment of Radiation Exposure
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,274,736Hematopoietic Growth Factor Proteins and Analogs Thereof and Angiotensin Converting Enzyme Inhibitors for Treatment of Radiation Exposure
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,306,931Method for Refolding Proteins Containing Free Cysteine Residues
Term ended
Term ended Aug 15, 2022 · High confidence
Term endedTerm ended Aug 15, 2022High confidence
US 7,754,855Immunoglobulin fusion proteins
Lapsed on the fee record
Ended Jul 13, 2022 · USPTO record
Lapsed on the fee recordEnded Jul 13, 2022USPTO record
US 6,753,165Methods for making proteins containing free cysteine residues
Term ended
Term ended Sep 6, 2021 · USPTO record
Term endedTerm ended Sep 6, 2021USPTO record
US 7,732,572Cysteine variants of alpha interferon-2
Term ended
Term ended Nov 9, 2020 · USPTO record
Term endedTerm ended Nov 9, 2020USPTO record
US 7,629,314Methods for making proteins containing free cysteine residues
Term ended
Term ended Aug 9, 2020 · USPTO record
Term endedTerm ended Aug 9, 2020USPTO record
US 7,399,839Monopegylated growth hormone proteins
Lapsed on the fee record
Ended Jul 15, 2020 · USPTO record
Lapsed on the fee recordEnded Jul 15, 2020USPTO record
US 8,932,828Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins
Term ended
Ended no later than May 16, 2020 · USPTO record
Term endedEnded no later than May 16, 2020USPTO record
US 6,608,183Derivatives of growth hormone and related proteins
Term ended
Term ended Jan 14, 2020 · USPTO record
Term endedTerm ended Jan 14, 2020USPTO record
10 of 39 patents shown.
Pro members see all 39.
Pro members: see all 39 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited